Scinopharm Taiwan Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their notable products is LIFITEGRAST, with a corresponding US DMF Number 35421.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 01, 2024, and payment made on June 06, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II